Interestingly, MCC cell lines have much lower steady-state levels of MDM2 as compared with those of the osteosarcoma cell line SJSA-1 and the choriocarcinoma cell line JAR with MDM2 amplification (Supplemental Figure 1C), but they have a similar range of milademetan IC50 values. Here, MDM2 is linked to osteosarcoma.